硫代磷酸化反义寡核苷酸抑制IL-10是安全强效的疫苗佐剂
该研究评估靶向IL-10的硫代磷酸化反义寡核苷酸(ASO)作为皮内接种免疫佐剂的安全性、效力与机制。结果显示,加入IL-10 ASO后模型抗原卵清蛋白(OVA)特异性抗体滴度较单独OVA提高100倍,免疫增强效力与弗氏不完全佐剂相似,且未检测到细胞或组织毒性;机制为暂时抑制局部树突状细胞IL-10表达并促进T细胞增殖。
要点
- IL-10 ASO作为佐剂使OVA特异性抗体滴度提高100倍。
- 免疫增强效力与弗氏不完全佐剂相似,未检测到细胞或组织毒性。
- 机制为暂时抑制局部树突状细胞IL-10表达,促进T细胞增殖。
核心结论
- IL-10 ASO能显著增强针对共递送疫苗抗原的免疫应答,高效低毒,有潜力开发为安全高效的免疫佐剂。
研究设计与样本
- 研究评估硫代磷酸化IL-10靶向反义寡核苷酸作为皮内接种免疫佐剂的安全性、效力与机制。
- 采用CCK-8法评估IL-10 ASO的细胞毒性及促进T细胞增殖的能力。
- 用ELISA测定接种局部组织中IL-6、IL-8、TNF-α、IL-1β和IL-10含量及小鼠血清抗原特异性抗体滴度。
- 用免疫荧光染色观察IL-10 ASO的靶细胞。
主要发现
- 加入IL-10 ASO作为佐剂后,模型抗原卵清蛋白(OVA)的特异性抗体滴度较单独OVA提高100倍。
- IL-10 ASO的免疫增强效力与弗氏不完全佐剂相似,未检测到细胞或组织毒性。
- 体外和体内实验证实IL-10 ASO通过暂时抑制局部树突状细胞IL-10表达并促进T细胞增殖来增强免疫应答。
临床怎么用
- IL-10 ASO作为皮内接种佐剂可显著增强抗原特异性抗体应答,且未检测到细胞或组织毒性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
While vaccination is highly effective for the prevention of many infectious diseases, the number of adjuvants licensed for human use is currently very limited. The aim of this study was to evaluate the safety, efficacy, and to clarify the mechanism of a phosphorothioated interleukin (IL)-10-targeted antisense oligonucleotide (ASO) as an immune adjuvant in intradermal vaccination. The cytotoxicity of IL-10 ASO and its ability to promote T cell proliferation were assessed by Cell Counting Kit-8 (CCK-8) assay. The contents of IL-6, IL-8, TNF-α, IL-1β, and IL-10 in inoculated local tissue and the antigen-specific antibody titers in mouse serum samples were determined by ELISA. The target cells of IL-10 ASO were observed using immunofluorescent staining. The results showed that the specific antibody titer of ovalbumin (OVA), a model antigen, was increased 100-fold upon addition of IL-10 ASO as an adjuvant compared to that of OVA alone. IL-10 ASO showed an immunopotentiation efficacy similar to that of Freund's incomplete adjuvant, with no detectable cell or tissue toxicity. In vitro and in vivo experiments confirmed that IL-10 ASO enhances immune responses by temporarily suppressing IL-10 expression from local dendritic cells and consequently promoting T cell proliferation. In conclusion, IL-10 ASO significantly enhances immune responses against co-delivered vaccine antigens with high efficacy and low toxicity. It has the potential to be developed into a safe and efficient immune adjuvant.
引用
- Zhang J, Liu N, Lu Y, et al. Phosphorothioated antisense oligodeoxynucleotide suppressing interleukin-10 is a safe and potent vaccine adjuvant. Vaccine. 2019. PMID: 31164303. doi:10.1016/j.vaccine.2019.05.076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。